Jaguar Health Inc 's

• JAGX's Stock Performance relative to its Competitors

Geron Corporation Share Performance +15.65% This Quarter

Geron Corporation Profile Geron Corp is a biopharmaceutical company that focuses on the discovery and development of therapeutic products for the treatment of cancer and chronic degenerative diseases. Their business model is based on researching and identifying innovative drug candidates, conducting preclinical and clinical trials to evaluate their safety and efficacy, and ultimately partnering with larger pharmaceutical companies for late-stage clinical development and commercialization. Geron Corp aims to leverage their scientific expertise and strategic collaborations to bring novel therapies to market and improve patient outcomes. More about Geron Corporation's Market Share

Processa Pharmaceuticals Inc Share Performance -36.86% This Year

Processa Pharmaceuticals Inc Profile Processa Pharmaceuticals Inc is a biopharmaceutical company that operates by developing and commercializing innovative drug candidates for various medical conditions. They focus on advancing treatments through clinical trials, obtaining regulatory approvals, and partnering with other healthcare organizations for distribution and marketing. More about Processa Pharmaceuticals Inc 's Market Share

Redhill Biopharma Ltd Share Performance -20.98% Over The Past 5 Days

Redhill Biopharma Ltd Profile Redhill Biopharma Ltd is a specialty pharmaceutical company focused on improving patient care and developing innovative treatments. Their business model revolves around advancing the research and development of drug candidates in therapeutic areas with unmet medical needs. By seeking partnerships and leveraging their in-house expertise, they aim to bring these potential treatments to market for the benefit of patients worldwide. More about Redhill Biopharma Ltd 's Market Share

Tvardi Therapeutics Inc Share Performance -57.60% This Year

Tvardi Therapeutics Inc Profile The company develops oral small molecule inhibitors targeting STAT3 for the treatment of inflammatory and proliferative diseases. More about Tvardi Therapeutics Inc 's Market Share

Inmed Pharmaceuticals Inc Share Performance -12.33% 30 Days

Inmed Pharmaceuticals Inc Profile Inmed Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of cannabinoid-based therapies for various diseases. The company's business model revolves around conducting research and development to identify novel drug candidates, conducting pre-clinical and clinical trials to test the safety and efficacy of these candidates, and seeking partnerships or collaborations with other pharmaceutical companies for the further development and commercialization of successful therapies. By leveraging advancements in cannabinoid science, Inmed Pharmaceuticals aims to provide innovative medical treatments for unmet medical needs. More about Inmed Pharmaceuticals Inc's Market Share

Sources: Jaguar Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:31 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Jaguar Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.